Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.52 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.33.
Market Cap
8.52T
Revenue
4.59T
Profits
201.21B
PE Ratio
42.33
Profit Margin
4.39%
Dividend Yield
0.43%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | 2.16% | 2,762,097 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 573.71B | -0.07% | 7,398,894 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 397.12B | -0.08% | 4,569,169 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 368.30B | -0.47% | 4,938,129 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 298.26B | 1.40% | 13,180,277 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 280.97B | 1.86% | 1,743,671 | 60.44B |
| 7 | NVS | Novartis AG | 278.13B | 3.92% | 2,128,669 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 193.08B | 2.69% | 12,719,828 | 50.57B |
| 9 | AMGN | Amgen Inc. | 191.09B | 4.84% | 4,727,085 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 176.77B | -1.32% | 1,776,637 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 156.28B | 3.61% | 8,665,054 | 29.74B |
| 12 | ABT | Abbott Laboratories | 156.15B | 0.54% | 15,088,358 | 45.13B |
| 13 | PFE | Pfizer Inc. | 149.15B | 2.23% | 45,268,227 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 146.23B | 0.21% | 1,998,409 | 10.58B |
| 15 | CVS | CVS Health Corporation | 128.21B | 2.51% | 14,115,290 | 405.62B |
| 16 | DHR | Danaher Corporation | 127.96B | -1.55% | 3,534,176 | 24.78B |
| 17 | SYK | Stryker Corporation | 117.17B | -1.04% | 2,030,121 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 116.19B | 2.34% | 8,900,245 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.95B | 2.14% | 1,233,681 | 12.22B |
| 20 | SNY | Sanofi | 105.53B | 1.24% | 3,207,006 | 54.60B |
| 21 | GSK | GSK plc | 104.52B | 3.30% | 5,018,471 | 43.29B |
| 22 | MDT | Medtronic plc | 103.13B | 0.10% | 8,411,606 | 36.36B |
| 23 | MCK | McKesson Corporation | 94.62B | -0.41% | 827,204 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 86.69B | -1.33% | 2,127,546 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.97B | 1.38% | 1,672,239 | 76.39B |
| 26 | CI | The Cigna Group | 77.99B | -0.33% | 1,132,596 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 70.11B | -2.42% | 18,900,056 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.21B | 1.63% | 943,127 | 14.92B |
| 29 | ARGX | argenx SE | 55.58B | 4.26% | 357,397 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.77B | 0.09% | 938,285 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 51.80B | 2.25% | 2,834,146 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 49.55B | 1.21% | 2,274,283 | 28.34B |
| 33 | EW | Edwards Lifesciences Corporation | 49.38B | -0.26% | 5,087,032 | 6.30B |
| 34 | MDLN | Medline Inc. | 48.78B | 1.61% | 9,480,329 | 29.14B |
| 35 | HUM | Humana Inc. | 44.27B | 1.16% | 1,097,661 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.01B | 0.17% | 612,161 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 40.60B | -0.30% | 1,639,735 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 40.24B | 2.92% | 7,228,633 | 17.35B |
| 39 | HLN | Haleon plc | 39.48B | -0.55% | 13,132,491 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.64B | -0.63% | 1,061,443 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 36.59B | -1.57% | 2,016,371 | 7.23B |
| 42 | WAT | Waters Corporation | 35.32B | -0.95% | 836,779 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 34.13B | 0.14% | 7,265,612 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.13B | 0.61% | 1,462,800 | 10.63B |
| 45 | RPRX | Royalty Pharma plc | 31.84B | 1.41% | 3,072,974 | 2.44B |
| 46 | RVMD | Revolution Medicines, Inc. | 31.73B | 3.50% | 2,201,974 | - |
| 47 | NTRA | Natera, Inc. | 31.40B | 1.26% | 735,963 | 2.50B |
| 48 | CNC | Centene Corporation | 31.38B | -2.75% | 6,336,805 | 178.33B |
| 49 | IQV | IQVIA Holdings Inc. | 30.22B | -0.61% | 1,605,570 | 16.63B |
| 50 | BIIB | Biogen Inc. | 29.52B | 2.94% | 914,742 | 9.94B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.35B | 1.18% | 3,060,531 | 20.98B |
| 52 | DXCM | DexCom, Inc. | 29.04B | 0.64% | 6,607,192 | 4.82B |
| 53 | ONC | BeOne Medicines AG | 28.94B | -1.27% | 505,561 | 5.70B |
| 54 | RMD | ResMed Inc. | 27.79B | -0.61% | 1,070,860 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 26.24B | -1.35% | 1,792,796 | 3.32B |
| 56 | ILMN | Illumina, Inc. | 25.15B | 2.30% | 1,486,924 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 24.44B | 1.71% | 1,211,214 | 20.34B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.34B | -0.18% | 524,111 | 3.22B |
| 59 | UTHR | United Therapeutics Corporation | 23.15B | 0.24% | 428,917 | 3.17B |
| 60 | MTD | Mettler-Toledo International Inc. | 23.06B | 0.73% | 113,360 | 4.09B |
| 61 | BNTX | BioNTech SE | 22.64B | 3.93% | 3,494,447 | 3.23B |
| 62 | DGX | Quest Diagnostics Incorporated | 22.56B | 0.02% | 1,079,971 | 11.28B |
| 63 | LH | Labcorp Holdings Inc. | 21.75B | -1.25% | 512,358 | 14.14B |
| 64 | INCY | Incyte Corporation | 21.54B | 2.32% | 2,318,442 | 5.36B |
| 65 | ROIV | Roivant Sciences Ltd. | 21.38B | 4.65% | 4,507,174 | 8.26M |
| 66 | INSM | Insmed Incorporated | 20.96B | 5.27% | 5,105,458 | 819.56M |
| 67 | STE | STERIS plc | 20.23B | -0.42% | 646,839 | 5.94B |
| 68 | MRNA | Moderna, Inc. | 19.70B | 7.94% | 6,196,217 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.99B | 3.42% | 11,081,917 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.36B | 0.15% | 1,502,548 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.86B | -1.17% | 1,995,839 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.36B | 1.15% | 764,659 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.30B | 3.06% | 1,173,452 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 14.92B | 5.10% | 1,677,718 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.82B | 2.85% | 954,534 | 4.44B |
| 76 | SOLV | Solventum Corporation | 13.72B | -2.13% | 1,449,344 | 8.26B |
| 77 | MEDP | Medpace Holdings, Inc. | 13.57B | 2.01% | 249,672 | 2.68B |
| 78 | EXEL | Exelixis, Inc. | 13.45B | 1.75% | 1,823,031 | 2.38B |
| 79 | ASND | Ascendis Pharma A/S | 13.39B | 2.77% | 694,866 | 998.25M |
| 80 | BBIO | BridgeBio Pharma, Inc. | 13.23B | 0.21% | 2,535,039 | 579.96M |
| 81 | COO | The Cooper Companies, Inc. | 13.17B | -0.27% | 3,244,992 | 4.23B |
| 82 | BTSG | BrightSpring Health Services, Inc. | 13.14B | 4.11% | 3,244,460 | 13.65B |
| 83 | DVA | DaVita Inc. | 13.09B | 2.66% | 849,680 | 13.84B |
| 84 | AXSM | Axsome Therapeutics, Inc. | 13.06B | 3.02% | 787,472 | 708.24M |
| 85 | SNN | Smith & Nephew plc | 12.86B | -0.74% | 1,172,728 | 6.16B |
| 86 | ALGN | Align Technology, Inc. | 12.64B | 3.52% | 1,029,596 | 4.10B |
| 87 | PEN | Penumbra, Inc. | 12.52B | -0.32% | 335,802 | 1.45B |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | 12.20B | 0.68% | 2,234,421 | 1.06B |
| 89 | ELAN | Elanco Animal Health Incorporated | 12.01B | 5.16% | 4,735,425 | 4.89B |
| 90 | FMS | Fresenius Medical Care AG | 11.98B | 0.40% | 603,762 | 22.32B |
| 91 | ICLR | ICON Public Limited Company | 11.48B | 3.69% | 790,289 | 8.25B |
| 92 | RVTY | Revvity, Inc. | 11.33B | 0.23% | 1,800,604 | 2.90B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.09B | 0.45% | 1,171,607 | 3.58B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.93B | 0.63% | 278,753 | 1.13B |
| 95 | GMED | Globus Medical, Inc. | 10.93B | -0.42% | 1,039,011 | 3.10B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.74B | -1.12% | 1,603,893 | 3.24B |
| 97 | BAX | Baxter International Inc. | 10.58B | 0.89% | 7,523,023 | 11.32B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.48B | 5.20% | 1,371,126 | 622.01M |
| 99 | PODD | Insulet Corporation | 10.33B | -1.01% | 1,501,745 | 2.90B |
| 100 | EHC | Encompass Health Corporation | 10.16B | -0.94% | 768,671 | 6.07B |
| 101 | SMMT | Summit Therapeutics Inc. | 10.15B | 0.23% | 9,289,765 | - |
| 102 | MOH | Molina Healthcare, Inc. | 10.06B | -2.37% | 1,144,936 | 43.10B |
| 103 | RGC | Regencell Bioscience Holdings Limited | 9.76B | -3.72% | 92,301 | - |
| 104 | NUVL | Nuvalent, Inc. | 9.75B | 0.08% | 6,582,086 | - |
| 105 | KRYS | Krystal Biotech, Inc. | 9.48B | 2.92% | 475,186 | 417.30M |
| 106 | CYTK | Cytokinetics, Incorporated | 9.40B | 3.28% | 1,443,205 | 105.82M |
| 107 | HSIC | Henry Schein, Inc. | 9.14B | 1.74% | 1,704,076 | 13.38B |
| 108 | CRL | Charles River Laboratories International, Inc. | 9.06B | 0.95% | 540,776 | 4.03B |
| 109 | CORT | Corcept Therapeutics Incorporated | 8.94B | 6.57% | 1,094,145 | 769.10M |
| 110 | TEM | Tempus AI, Inc. | 8.90B | 0.22% | 6,587,857 | 1.36B |
| 111 | UHS | Universal Health Services, Inc. | 8.84B | 0.85% | 905,984 | 17.76B |
| 112 | OSCR | Oscar Health, Inc. | 8.71B | 3.81% | 6,995,274 | 13.30B |
| 113 | ENSG | The Ensign Group, Inc. | 8.53B | -2.98% | 2,186,493 | 5.27B |
| 114 | TECH | Bio-Techne Corporation | 8.46B | 2.90% | 2,619,697 | 1.21B |
| 115 | BRKR | Bruker Corporation | 8.40B | 0.47% | 2,255,833 | 3.46B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.39B | 0.33% | 1,344,180 | 1.51B |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 7.83B | 0.49% | 370,655 | 2.59B |
| 118 | ABVX | ABIVAX Société Anonyme | 7.82B | 2.90% | 1,175,548 | 5.67M |
| 119 | QGEN | Qiagen N.V. | 7.74B | 1.08% | 2,623,060 | 2.10B |
| 120 | IBRX | ImmunityBio, Inc. | 7.54B | 3.15% | 8,611,272 | 140.98M |
| 121 | RGEN | Repligen Corporation | 7.52B | 1.98% | 641,409 | 763.34M |
| 122 | ALKS | Alkermes plc | 7.49B | 2.46% | 2,249,616 | 1.56B |
| 123 | ATR | AptarGroup, Inc. | 7.44B | 1.67% | 395,181 | 3.87B |
| 124 | HQY | HealthEquity, Inc. | 7.44B | -0.78% | 568,027 | 1.34B |
| 125 | GKOS | Glaukos Corporation | 7.29B | 1.45% | 629,397 | 551.35M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 7.06B | 3.80% | 564,219 | 74.06M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 7.01B | 7.58% | 1,260,969 | - |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 6.91B | 3.04% | 428,873 | 7.46M |
| 129 | PCVX | Vaxcyte, Inc. | 6.83B | 4.12% | 2,039,015 | - |
| 130 | KYMR | Kymera Therapeutics, Inc. | 6.82B | 6.05% | 674,479 | 51.48M |
| 131 | TGTX | TG Therapeutics, Inc. | 6.81B | 3.07% | 2,531,312 | 700.35M |
| 132 | LNTH | Lantheus Holdings, Inc. | 6.79B | 4.07% | 1,226,179 | 1.55B |
| 133 | IMVT | Immunovant, Inc. | 6.75B | 5.45% | 1,203,760 | - |
| 134 | LEGN | Legend Biotech Corporation | 6.74B | 4.07% | 1,975,845 | 1.14B |
| 135 | APGE | Apogee Therapeutics, Inc. | 6.71B | 8.20% | 792,670 | - |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.68B | 3.92% | 13,860,889 | 2.37B |
| 137 | AVTR | Avantor, Inc. | 6.60B | 0.10% | 5,206,318 | 6.55B |
| 138 | LQDA | Liquidia Corporation | 6.37B | 9.77% | 3,321,958 | 288.07M |
| 139 | GRFS | Grifols, S.A. | 6.23B | 2.32% | 702,471 | 8.58B |
| 140 | PTCT | PTC Therapeutics, Inc. | 6.20B | 1.85% | 2,245,423 | 827.11M |
| 141 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.20% | 871,057 | 15.00M |
| 142 | MIRM | Mirum Pharmaceuticals, Inc. | 6.07B | 5.89% | 687,766 | 569.61M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.01B | 2.28% | 684,067 | 217.17M |
| 144 | TFX | Teleflex Incorporated | 5.72B | -2.15% | 549,271 | 2.13B |
| 145 | COGT | Cogent Biosciences, Inc. | 5.58B | 3.95% | 1,823,425 | - |
| 146 | CHE | Chemed Corporation | 5.56B | -3.12% | 265,033 | 2.54B |
| 147 | PACS | PACS Group, Inc. | 5.50B | 1.25% | 754,838 | 5.43B |
| 148 | BLCO | Bausch + Lomb Corporation | 5.45B | 0.20% | 340,359 | 5.21B |
| 149 | BLTE | Belite Bio, Inc | 5.38B | 0.17% | 180,565 | - |
| 150 | SRRK | Scholar Rock Holding Corporation | 5.36B | 1.36% | 976,174 | - |
| 151 | AMRX | Amneal Pharmaceuticals, Inc. | 5.21B | 6.66% | 3,073,434 | 3.05B |
| 152 | LGND | Ligand Pharmaceuticals Incorporated | 5.10B | 2.55% | 274,594 | 274.48M |
| 153 | CAI | Caris Life Sciences, Inc. | 5.09B | 4.90% | 2,384,753 | 907.29M |
| 154 | CGON | CG Oncology, Inc. | 5.08B | 4.99% | 772,474 | 5.07M |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 5.04B | 1.66% | 1,727,197 | 7.50M |
| 156 | HNGE | Hinge Health, Inc. | 5.01B | 4.33% | 2,448,180 | 646.34M |
| 157 | CRSP | CRISPR Therapeutics AG | 4.84B | 1.60% | 1,514,711 | 4.10M |
| 158 | STVN | Stevanato Group S.p.A. | 4.72B | 0.60% | 822,257 | 1.39B |
| 159 | SHC | Sotera Health Company | 4.67B | 0.74% | 3,826,930 | 1.19B |
| 160 | TWST | Twist Bioscience Corporation | 4.61B | 9.27% | 2,742,770 | 409.48M |
| 161 | BLLN | BillionToOne, Inc. | 4.58B | 0.39% | 668,181 | 354.54M |
| 162 | RDNT | RadNet, Inc. | 4.58B | 0.07% | 626,443 | 2.14B |
| 163 | TVTX | Travere Therapeutics, Inc. | 4.55B | 4.64% | 2,639,289 | 536.20M |
| 164 | LIVN | LivaNova PLC | 4.39B | 1.99% | 799,675 | 1.43B |
| 165 | CELC | Celcuity Inc. | 4.36B | 1.42% | 1,603,291 | - |
| 166 | ERAS | Erasca, Inc. | 4.36B | 4.79% | 5,704,055 | - |
| 167 | MMED | MiniMed Group, Inc. | 4.34B | 5.17% | 1,413,697 | 3.10B |
| 168 | TNGX | Tango Therapeutics, Inc. | 4.31B | 3.97% | 6,446,055 | 56.99M |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.18B | -1.56% | 6,586,593 | 4.26B |
| 170 | DNTH | Dianthus Therapeutics, Inc. | 4.18B | 0.04% | 1,441,847 | 1.34M |
| 171 | ORKA | Oruka Therapeutics, Inc. | 4.13B | 6.93% | 1,188,734 | - |
| 172 | MMSI | Merit Medical Systems, Inc. | 3.99B | -0.15% | 644,099 | 1.54B |
| 173 | NVST | Envista Holdings Corporation | 3.99B | 1.83% | 2,348,734 | 2.81B |
| 174 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.97B | 4.69% | 624,156 | 754.05M |
| 175 | MANE | Veradermics, Incorporated | 3.94B | 1.53% | 206,457 | - |
| 176 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.10% | 1,020,825 | 596.96M |
| 177 | VCYT | Veracyte, Inc. | 3.78B | -1.56% | 1,044,532 | 541.74M |
| 178 | IRTC | iRhythm Holdings, Inc. | 3.70B | -1.11% | 354,015 | 787.85M |
| 179 | TXG | 10x Genomics, Inc. | 3.69B | -0.21% | 2,960,418 | 638.78M |
| 180 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | 0.66% | 945,091 | 1.10B |
| 181 | DOCS | Doximity, Inc. | 3.66B | -1.09% | 3,033,162 | 644.86M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.65B | 3.07% | 1,063,762 | - |
| 183 | HAE | Haemonetics Corporation | 3.63B | 1.32% | 1,749,815 | 1.33B |
| 184 | PBLS | Parabilis Medicines, Inc. | 3.58B | -4.08% | 1,599,809 | - |
| 185 | ICUI | ICU Medical, Inc. | 3.57B | 2.21% | 237,402 | 2.16B |
| 186 | WAY | Waystar Holding Corp. | 3.54B | -1.86% | 1,667,149 | 1.16B |
| 187 | NAMS | NewAmsterdam Pharma Company N.V. | 3.54B | 3.10% | 2,053,070 | 22.57M |
| 188 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.54B | -2.30% | 1,776,575 | 18.07M |
| 189 | OGN | Organon & Co. | 3.53B | 0.52% | 4,187,159 | 6.16B |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.49B | 2.37% | 1,429,282 | 2.23B |
| 191 | LFST | LifeStance Health Group, Inc. | 3.34B | 9.54% | 6,073,108 | 1.49B |
| 192 | DNLI | Denali Therapeutics Inc. | 3.34B | 1.99% | 1,964,652 | - |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.32B | 3.10% | 2,667,225 | - |
| 194 | OPCH | Option Care Health, Inc. | 3.26B | -2.81% | 2,799,999 | 5.67B |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.23B | 0.11% | 338,340 | 803.79M |
| 196 | WRBY | Warby Parker Inc. | 3.17B | 3.36% | 3,021,570 | 890.57M |
| 197 | ITGR | Integer Holdings Corporation | 3.13B | 0.80% | 335,693 | 1.86B |
| 198 | RLAY | Relay Therapeutics, Inc. | 3.10B | 5.56% | 2,092,696 | 10.68M |
| 199 | BKD | Brookdale Senior Living Inc. | 3.09B | -1.22% | 3,407,150 | 3.00B |
| 200 | GPCR | Structure Therapeutics Inc. | 3.08B | 4.26% | 1,023,201 | - |
| 201 | ARQT | Arcutis Biotherapeutics, Inc. | 3.08B | 5.85% | 2,748,967 | 415.62M |
| 202 | NHC | National HealthCare Corporation | 3.06B | 2.16% | 96,371 | 1.53B |
| 203 | ADPT | Adaptive Biotechnologies Corporation | 3.00B | 9.72% | 5,433,572 | 295.41M |
| 204 | DYN | Dyne Therapeutics, Inc. | 2.97B | 1.58% | 1,980,824 | - |
| 205 | PRVA | Privia Health Group, Inc. | 2.94B | 2.01% | 956,504 | 2.25B |
| 206 | RCUS | Arcus Biosciences, Inc. | 2.93B | 5.33% | 1,285,269 | 236.00M |
| 207 | BEAM | Beam Therapeutics Inc. | 2.93B | -0.27% | 1,931,529 | 164.01M |
| 208 | GRDN | Guardian Pharmacy Services, Inc. | 2.73B | 2.64% | 306,655 | 1.46B |
| 209 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | 2.19% | 399,703 | 535.08M |
| 210 | ALMS | Alumis Inc. | 2.66B | 4.19% | 1,705,312 | 8.40M |
| 211 | HTFL | HeartFlow, Inc. | 2.65B | 4.21% | 1,357,317 | 191.42M |
| 212 | SUPN | Supernus Pharmaceuticals, Inc. | 2.64B | 0.90% | 478,342 | 776.83M |
| 213 | DFTX | Definium Therapeutics, Inc. | 2.63B | 3.74% | 2,369,187 | - |
| 214 | IRON | Disc Medicine, Inc. | 2.60B | 1.23% | 219,633 | - |
| 215 | GRAL | GRAIL, Inc. | 2.58B | 2.68% | 596,698 | 156.12M |
| 216 | CLOV | Clover Health Investments, Corp. | 2.58B | 0.20% | 16,891,260 | 2.21B |
| 217 | TMDX | TransMedics Group, Inc. | 2.54B | -1.58% | 941,482 | 635.89M |
| 218 | IDYA | IDEAYA Biosciences, Inc. | 2.53B | 4.49% | 1,361,746 | 225.27M |
| 219 | KLRA | Kailera Therapeutics, Inc. | 2.53B | 2.09% | 376,865 | - |
| 220 | ESTA | Establishment Labs Holdings Inc. | 2.50B | 7.11% | 644,551 | 229.58M |
| 221 | ELVN | Enliven Therapeutics, Inc. | 2.46B | 9.08% | 5,099,623 | - |
| 222 | VERA | Vera Therapeutics, Inc. | 2.42B | 6.42% | 884,387 | - |
| 223 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 4.40% | 1,527,247 | 670.00M |
| 224 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 2.08% | 949,714 | 865.00K |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.29B | 4.10% | 2,611,246 | 3.37B |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.25B | -3.18% | 571,065 | 1.09B |
| 227 | AXGN | Axogen, Inc. | 2.25B | 2.47% | 1,761,885 | 238.11M |
| 228 | PHVS | Pharvaris N.V. | 2.24B | 2.19% | 396,728 | - |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.16B | 3.79% | 3,820,257 | 885.72M |
| 230 | KOD | Kodiak Sciences Inc. | 2.12B | 8.15% | 593,797 | - |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.11B | - | 558,195 | 256.28M |
| 232 | IMNM | Immunome, Inc. | 2.08B | 1.10% | 2,002,585 | 4.02M |
| 233 | SEM | Select Medical Holdings Corporation | 2.07B | 0.36% | 1,565,616 | 5.52B |
| 234 | NVCR | NovoCure Limited | 2.05B | 6.37% | 1,348,095 | 674.41M |
| 235 | AUPH | Aurinia Pharmaceuticals Inc. | 2.04B | 1.21% | 905,365 | 298.30M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | -0.79% | 820,480 | 899.11M |
| 237 | XRAY | DENTSPLY SIRONA Inc. | 2.03B | 1.00% | 4,542,882 | 3.68B |
| 238 | NEOG | Neogen Corporation | 2.01B | 0.82% | 1,150,490 | 870.56M |
| 239 | PGNY | Progyny, Inc. | 2.01B | -0.93% | 1,200,822 | 1.29B |
| 240 | NKTR | Nektar Therapeutics | 2.00B | 4.28% | 794,674 | 55.63M |
| 241 | ZLAB | Zai Lab Limited | 1.98B | 2.20% | 1,004,925 | 453.28M |
| 242 | ASTH | Astrana Health, Inc. | 1.98B | 2.89% | 745,640 | 3.53B |
| 243 | MLYS | Mineralys Therapeutics, Inc. | 1.98B | 0.76% | 1,544,229 | - |
| 244 | VCEL | Vericel Corporation | 1.97B | 3.18% | 505,196 | 292.09M |
| 245 | HCM | HUTCHMED (China) Limited | 1.94B | -1.75% | 57,684 | 548.51M |
| 246 | AGL | agilon health, inc. | 1.94B | 14.22% | 211,302 | 5.82B |
| 247 | MD | Pediatrix Medical Group, Inc. | 1.94B | 2.55% | 664,690 | 1.93B |
| 248 | SGRY | Surgery Partners, Inc. | 1.94B | 5.21% | 1,370,795 | 3.34B |
| 249 | ADMA | ADMA Biologics, Inc. | 1.93B | -1.89% | 4,474,636 | 509.86M |
| 250 | BHC | Bausch Health Companies Inc. | 1.93B | 0.19% | 1,441,090 | 10.53B |
| 251 | TRVI | Trevi Therapeutics, Inc. | 1.91B | 0.45% | 641,867 | - |
| 252 | OCUL | Ocular Therapeutix, Inc. | 1.90B | -0.46% | 2,765,380 | 52.04M |
| 253 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 1.01% | 161,242 | 1.20B |
| 254 | PLSE | Pulse Biosciences, Inc. | 1.86B | 7.60% | 450,963 | 751.00K |
| 255 | UFPT | UFP Technologies, Inc. | 1.85B | 2.63% | 269,956 | 608.85M |
| 256 | STOK | Stoke Therapeutics, Inc. | 1.83B | 3.09% | 498,438 | 32.08M |
| 257 | WGS | GeneDx Holdings Corp. | 1.81B | 12.28% | 1,876,122 | 442.68M |
| 258 | MESO | Mesoblast Limited | 1.79B | 2.32% | 104,246 | 65.38M |
| 259 | VRDN | Viridian Therapeutics, Inc. | 1.78B | 2.35% | 1,529,173 | 70.92M |
| 260 | MBX | MBX Biosciences, Inc. | 1.77B | 20.20% | 2,732,257 | - |
| 261 | IOVA | Iovance Biotherapeutics, Inc. | 1.77B | 4.76% | 11,510,806 | 285.61M |
| 262 | NRIX | Nurix Therapeutics, Inc. | 1.76B | 10.98% | 4,029,635 | 71.78M |
| 263 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | -0.24% | 167,709 | 923.71M |
| 264 | NTLA | Intellia Therapeutics, Inc. | 1.73B | 1.23% | 7,935,809 | 66.09M |
| 265 | OMCL | Omnicell, Inc. | 1.72B | -0.94% | 1,376,379 | 1.23B |
| 266 | BHVN | Biohaven Ltd. | 1.71B | 2.71% | 4,384,768 | - |
| 267 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | -0.38% | 2,171,770 | 66.05M |
| 268 | ADUS | Addus HomeCare Corporation | 1.70B | -0.14% | 189,684 | 1.45B |
| 269 | NBTX | Nanobiotix S.A. | 1.69B | 4.04% | 84,361 | 38.27M |
| 270 | QURE | uniQure N.V. | 1.69B | - | 1,309,176 | 18.09M |
| 271 | RAPP | Rapport Therapeutics, Inc. | 1.68B | - | 1,063,276 | 20.00M |
| 272 | ZYME | Zymeworks Inc. | 1.68B | 0.50% | 1,109,330 | 81.26M |
| 273 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | 3.62% | 25,424,629 | 66.41M |
| 274 | GENB | Generate Biomedicines, Inc. | 1.66B | -1.75% | 511,541 | 30.30M |
| 275 | NUVB | Nuvation Bio Inc. | 1.66B | 3.93% | 3,457,391 | 143.05M |
| 276 | INVA | Innoviva, Inc. | 1.66B | -2.43% | 762,804 | 420.69M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.64B | -2.09% | 595,417 | 367.34M |
| 278 | SION | Sionna Therapeutics, Inc. | 1.63B | 5.94% | 398,960 | - |
| 279 | PGEN | Precigen, Inc. | 1.61B | 16.45% | 9,956,279 | 31.60M |
| 280 | ABCL | AbCellera Biologics Inc. | 1.61B | 3.54% | 4,170,894 | 79.21M |
| 281 | TSHA | Taysha Gene Therapies, Inc. | 1.60B | 3.33% | 1,545,244 | 7.47M |
| 282 | FTRE | Fortrea Holdings Inc. | 1.60B | 3.24% | 1,240,655 | 2.71B |
| 283 | SNDX | Syndax Pharmaceuticals, Inc. | 1.59B | 1.88% | 1,579,377 | 217.17M |
| 284 | SRPT | Sarepta Therapeutics, Inc. | 1.58B | -0.73% | 2,758,816 | 2.18B |
| 285 | ANAB | AnaptysBio, Inc. | 1.58B | 4.11% | 525,215 | 232.39M |
| 286 | AAPG | Ascentage Pharma Group International | 1.58B | 0.23% | 1,670 | 82.08M |
| 287 | PRCT | PROCEPT BioRobotics Corporation | 1.58B | -4.81% | 2,589,271 | 322.02M |
| 288 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.55B | 3.34% | 2,078,330 | -665.00K |
| 289 | CMPS | COMPASS Pathways plc | 1.54B | 3.45% | 3,696,919 | - |
| 290 | ALMR | Alamar Biosciences, Inc. | 1.54B | 3.16% | 131,330 | 87.16M |
| 291 | SEPN | Septerna, Inc. | 1.53B | 11.68% | 513,326 | 72.26M |
| 292 | PVLA | Palvella Therapeutics, Inc. | 1.53B | 4.10% | 210,912 | - |
| 293 | AVAH | Aveanna Healthcare Holdings Inc. | 1.52B | 1.60% | 1,551,139 | 2.52B |
| 294 | TYRA | Tyra Biosciences, Inc. | 1.52B | 0.59% | 1,298,263 | - |
| 295 | PRGO | Perrigo Company plc | 1.51B | -2.42% | 3,561,443 | 4.18B |
| 296 | NEO | NeoGenomics, Inc. | 1.49B | 1.68% | 2,313,089 | 745.97M |
| 297 | BFLY | Butterfly Network, Inc. | 1.49B | 5.38% | 7,104,043 | 102.92M |
| 298 | NVAX | Novavax, Inc. | 1.48B | 5.49% | 3,573,359 | 596.34M |
| 299 | HCSG | Healthcare Services Group, Inc. | 1.48B | 1.27% | 622,359 | 1.85B |
| 300 | IMCR | Immunocore Holdings plc | 1.46B | 2.58% | 412,681 | 412.81M |
| 301 | CAPR | Capricor Therapeutics, Inc. | 1.45B | -1.14% | 1,220,493 | 11.13M |
| 302 | GLUE | Monte Rosa Therapeutics, Inc. | 1.44B | 3.51% | 1,386,997 | 42.95M |
| 303 | SLS | SELLAS Life Sciences Group, Inc. | 1.44B | 8.39% | 6,268,357 | - |
| 304 | STAA | STAAR Surgical Company | 1.44B | -1.47% | 613,328 | 290.38M |
| 305 | ATRC | AtriCure, Inc. | 1.44B | 3.27% | 1,105,117 | 552.16M |
| 306 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | - | - | 114.48M |
| 307 | URGN | UroGen Pharma Ltd. | 1.44B | 5.36% | 528,559 | 140.49M |
| 308 | VIR | Vir Biotechnology, Inc. | 1.44B | 3.27% | 1,371,701 | 65.50M |
| 309 | ARDX | Ardelyx, Inc. | 1.43B | 3.21% | 3,651,785 | 427.68M |
| 310 | GHRS | GH Research PLC | 1.42B | 1.47% | 220,235 | - |
| 311 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -0.95% | 432,455 | - |
| 312 | HROW | Harrow, Inc. | 1.40B | 4.87% | 872,648 | 268.68M |
| 313 | ATAI | AtaiBeckley Inc. | 1.40B | 0.53% | 4,858,494 | 3.49M |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.40B | 5.29% | 567,151 | - |
| 315 | ARDT | Ardent Health, Inc. | 1.39B | 3.76% | 564,087 | 6.43B |
| 316 | MPLT | MapLight Therapeutics, Inc. | 1.38B | 9.17% | 255,453 | - |
| 317 | INBX | Inhibrx Biosciences, Inc. | 1.37B | 4.55% | 359,492 | 1.30M |
| 318 | IART | Integra LifeSciences Holdings Corporation | 1.36B | 2.46% | 580,636 | 1.64B |
| 319 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.35B | 2.56% | 2,740,813 | 204.73M |
| 320 | AHCO | AdaptHealth Corp. | 1.34B | 1.71% | 904,581 | 3.29B |
| 321 | SVRA | Savara Inc. | 1.34B | 3.54% | 1,535,376 | - |
| 322 | MAZE | Maze Therapeutics, Inc. | 1.33B | 1.82% | 643,213 | 20.00M |
| 323 | TDOC | Teladoc Health, Inc. | 1.32B | 3.98% | 3,791,116 | 2.51B |
| 324 | ALVO | Alvotech | 1.32B | 1.93% | 896,646 | 562.04M |
| 325 | DMRA | Damora Therapeutics, Inc. | 1.31B | 6.00% | 313,199 | - |
| 326 | MLTX | MoonLake Immunotherapeutics | 1.31B | 1.49% | 726,205 | - |
| 327 | BLFS | BioLife Solutions, Inc. | 1.30B | -0.23% | 503,855 | 101.66M |
| 328 | PAHC | Phibro Animal Health Corporation | 1.27B | 0.26% | 262,687 | 1.50B |
| 329 | ATEC | Alphatec Holdings, Inc. | 1.25B | - | 2,644,266 | 787.08M |
| 330 | INNV | InnovAge Holding Corp. | 1.24B | 10.28% | 357,334 | 949.17M |
| 331 | IMTX | Immatics N.V. | 1.24B | 2.14% | 236,577 | 43.00M |
| 332 | IRMD | IRADIMED CORPORATION | 1.23B | 0.27% | 155,741 | 86.28M |
| 333 | INSP | Inspire Medical Systems, Inc. | 1.22B | 0.38% | 971,055 | 915.25M |
| 334 | CDNA | CareDx, Inc. | 1.22B | 0.85% | 839,538 | 412.82M |
| 335 | ENOV | Enovis Corporation | 1.22B | -3.87% | 1,502,430 | 2.28B |
| 336 | XERS | Xeris Biopharma Holdings, Inc. | 1.20B | 3.28% | 3,135,310 | 314.85M |
| 337 | AMN | AMN Healthcare Services, Inc. | 1.19B | 4.80% | 768,945 | 3.42B |
| 338 | COAG | Hemab Therapeutics Holdings, Inc. | 1.19B | 4.70% | 190,950 | - |
| 339 | KMTS | Kestra Medical Technologies, Ltd. | 1.18B | 3.60% | 138,376 | 83.72M |
| 340 | AHG | Akso Health Group | 1.17B | -1.44% | 1,872 | 14.84M |
| 341 | AVLN | Avalyn Pharma Inc. | 1.17B | -1.61% | 199,614 | - |
| 342 | AVNS | Avanos Medical, Inc. | 1.17B | - | 1,279,035 | 715.90M |
| 343 | MNKD | MannKind Corporation | 1.16B | 3.31% | 4,071,346 | 360.78M |
| 344 | PNTG | The Pennant Group, Inc. | 1.14B | 1.49% | 124,783 | 1.02B |
| 345 | ZBIO | Zenas BioPharma, Inc. | 1.12B | -0.84% | 607,217 | 10.00M |
| 346 | WVE | Wave Life Sciences Ltd. | 1.12B | 2.65% | 3,154,581 | 71.80M |
| 347 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | -1.32% | 461,374 | 796.33M |
| 348 | OPK | OPKO Health, Inc. | 1.09B | 0.69% | 2,062,026 | 581.12M |
| 349 | SDGR | Schrödinger, Inc. | 1.09B | 3.18% | 920,541 | 254.91M |
| 350 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | -2.65% | 3,626,756 | 1.03B |
| 351 | AKTS | Aktis Oncology, Inc. | 1.08B | 4.74% | 137,059 | 8.28M |
| 352 | OMDA | Omada Health, Inc. | 1.05B | 3.68% | 814,754 | 283.30M |
| 353 | EYPT | EyePoint, Inc. | 1.05B | 1.38% | 1,260,368 | 7.61M |
| 354 | CNMD | CONMED Corporation | 1.04B | -5.21% | 532,448 | 1.37B |
| 355 | AZTA | Azenta, Inc. | 1.04B | 0.36% | 1,042,006 | 596.48M |
| 356 | CRON | Cronos Group Inc. | 1.03B | 0.36% | 885,972 | 159.54M |
| 357 | ABSI | Absci Corporation | 1.01B | 2.04% | 3,785,798 | 1.84M |
| 358 | NUTX | Nutex Health Inc. | 1.01B | 10.03% | 174,420 | 879.95M |
| 359 | USPH | U.S. Physical Therapy, Inc. | 1.00B | 4.71% | 192,400 | 787.69M |
| 360 | AORT | Artivion, Inc. | 999.99M | 0.64% | 793,464 | 458.69M |
| 361 | PSNL | Personalis, Inc. | 986.47M | -1.98% | 3,685,184 | 64.52M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 975.45M | 3.94% | 1,140,153 | - |
| 363 | DBVT | DBV Technologies S.A. | 962.97M | 3.12% | 92,219 | 5.74M |
| 364 | QDEL | QuidelOrtho Corporation | 960.81M | 4.37% | 2,262,549 | 2.66B |
| 365 | JBIO | Jade Biosciences, Inc. | 954.51M | 5.24% | 806,432 | - |
| 366 | EVO | Evotec SE | 953.68M | 4.21% | 34,639 | 859.03M |
| 367 | SPRY | ARS Pharmaceuticals, Inc. | 952.32M | 3.56% | 989,799 | 98.99M |
| 368 | SPTX | Seaport Therapeutics, Inc. | 939.65M | 3.97% | 129,074 | - |
| 369 | AVR | Anteris Technologies Global Corp. | 919.22M | -2.00% | 977,888 | 1.85M |
| 370 | PCRX | Pacira BioSciences, Inc. | 919.17M | -0.26% | 395,655 | 734.86M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 914.69M | 5.31% | 934,725 | 1.03B |
| 372 | AMPH | Amphastar Pharmaceuticals, Inc. | 905.23M | 1.28% | 463,541 | 720.53M |
| 373 | XNCR | Xencor, Inc. | 896.37M | 2.20% | 500,302 | 97.36M |
| 374 | PHAR | Pharming Group N.V. | 894.01M | 4.89% | 2,396 | 369.49M |
| 375 | GDRX | GoodRx Holdings, Inc. | 890.72M | 2.73% | 1,077,764 | 787.89M |
| 376 | MGTX | MeiraGTx Holdings plc | 889.05M | 5.03% | 876,148 | 79.76M |
| 377 | ETON | Eton Pharmaceuticals, Inc. | 879.57M | 3.75% | 263,564 | 86.93M |
| 378 | DRTS | Alpha Tau Medical Ltd. | 872.90M | 4.76% | 700,809 | - |
| 379 | TALK | Talkspace, Inc. | 872.74M | - | 2,817,663 | 238.37M |
| 380 | INMD | InMode Ltd. | 854.71M | 0.15% | 515,488 | 374.64M |
| 381 | OLMA | Olema Pharmaceuticals, Inc. | 851.64M | -0.71% | 1,985,097 | - |
| 382 | TBPH | Theravance Biopharma, Inc. | 850.11M | 0.73% | 289,927 | 109.78M |
| 383 | ABUS | Arbutus Biopharma Corporation | 847.44M | 4.13% | 1,895,633 | 191.45M |
| 384 | LXRX | Lexicon Pharmaceuticals, Inc. | 839.53M | 0.53% | 2,041,413 | 69.64M |
| 385 | JANX | Janux Therapeutics, Inc. | 833.05M | 4.03% | 1,007,073 | 13.73M |
| 386 | CERT | Certara, Inc. | 819.83M | 1.74% | 5,140,947 | 419.75M |
| 387 | LBRX | LB Pharmaceuticals Inc | 818.43M | 0.53% | 120,333 | - |
| 388 | PHAT | Phathom Pharmaceuticals, Inc. | 815.75M | 4.58% | 796,611 | 204.89M |
| 389 | ESPR | Esperion Therapeutics, Inc. | 810.91M | 0.32% | 9,844,866 | 418.24M |
| 390 | ORIC | ORIC Pharmaceuticals, Inc. | 809.51M | 3.71% | 2,187,522 | - |
| 391 | CGEM | Cullinan Therapeutics, Inc. | 797.73M | 7.72% | 1,216,234 | - |
| 392 | ODTX | Odyssey Therapeutics, Inc. | 793.00M | 3.77% | 212,672 | 2.98M |
| 393 | IVA | Inventiva S.A. | 792.25M | 0.53% | 831,749 | 7.94M |
| 394 | KURA | Kura Oncology, Inc. | 786.54M | 2.07% | 2,230,788 | 71.64M |
| 395 | SANA | Sana Biotechnology, Inc. | 770.87M | -1.77% | 2,951,970 | - |
| 396 | ANNX | Annexon, Inc. | 770.06M | -0.42% | 1,673,915 | - |
| 397 | ZVRA | Zevra Therapeutics, Inc. | 766.72M | -3.93% | 2,232,562 | 122.29M |
| 398 | HSTM | HealthStream, Inc. | 766.02M | -0.38% | 218,568 | 311.78M |
| 399 | VOR | Vor Biopharma Inc. | 763.48M | 8.38% | 1,045,273 | - |
| 400 | ANRO | Alto Neuroscience, Inc. | 752.06M | 8.89% | 336,770 | - |
| 401 | EVMN | Evommune, Inc. | 745.22M | 0.98% | 810,693 | 10.00M |
| 402 | OMER | Omeros Corporation | 736.78M | -0.20% | 1,097,428 | 9.89M |
| 403 | GERN | Geron Corporation | 731.33M | 3.64% | 31,745,972 | 196.12M |
| 404 | BIOA | BioAge Labs, Inc. | 731.25M | 6.27% | 629,286 | 10.32M |
| 405 | BVS | Bioventus Inc. | 725.08M | -4.09% | 593,363 | 576.30M |
| 406 | NNNN | Anbio Biotechnology | 721.57M | 0.06% | 54,931 | 8.65M |
| 407 | AVTX | Avalo Therapeutics, Inc. | 718.57M | 4.35% | 817,163 | 59.00K |
| 408 | REPL | Replimune Group, Inc. | 711.78M | 1.77% | 2,052,747 | - |
| 409 | SLDB | Solid Biosciences Inc. | 710.81M | 9.23% | 2,901,683 | - |
| 410 | SSII | SS Innovations International, Inc. | 706.46M | 0.28% | 66,594 | 48.47M |
| 411 | CRMD | CorMedix Inc. | 702.93M | 2.17% | 1,237,832 | 400.05M |
| 412 | GMRS | GMR Solutions Inc. | 697.29M | -2.05% | 788,559 | 5.83B |
| 413 | CBLL | CeriBell, Inc. | 688.66M | -1.25% | 242,678 | 95.07M |
| 414 | AURA | Aura Biosciences, Inc. | 684.96M | 1.47% | 816,602 | - |
| 415 | RLMD | Relmada Therapeutics, Inc. | 683.88M | 2.19% | 865,359 | - |
| 416 | SIBN | SI-BONE, Inc. | 671.45M | -1.50% | 336,944 | 206.22M |
| 417 | OCS | Oculis Holding AG | 664.27M | 0.27% | 428,129 | 1.40M |
| 418 | DSGN | Design Therapeutics, Inc. | 657.67M | -1.22% | 696,584 | - |
| 419 | BBNX | Beta Bionics, Inc. | 654.61M | 7.07% | 1,515,251 | 110.24M |
| 420 | ALLO | Allogene Therapeutics, Inc. | 648.89M | 5.62% | 6,102,343 | 22.00K |
| 421 | CTMX | CytomX Therapeutics, Inc. | 648.75M | 2.41% | 2,271,723 | 35.54M |
| 422 | CSTL | Castle Biosciences, Inc. | 637.23M | -0.47% | 215,205 | 339.92M |
| 423 | TENX | Tenax Therapeutics, Inc. | 631.76M | 1.71% | 948,694 | - |
| 424 | TLRY | Tilray Brands, Inc. | 610.73M | 1.99% | 2,792,750 | 858.28M |
| 425 | ACRS | Aclaris Therapeutics, Inc. | 610.33M | 6.59% | 818,744 | 8.37M |
| 426 | CBIO | Crescent Biopharma, Inc. | 609.42M | 4.38% | 139,252 | 11.88M |
| 427 | SGP | SpyGlass Pharma, Inc. | 604.69M | 1.07% | 77,844 | - |
| 428 | DRUG | Bright Minds Biosciences Inc. | 601.15M | 0.02% | 582,739 | - |
| 429 | CADL | Candel Therapeutics, Inc. | 597.89M | -2.28% | 1,880,566 | - |
| 430 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 597.60M | 4.78% | 286,081 | - |
| 431 | IRWD | Ironwood Pharmaceuticals, Inc. | 597.55M | 8.36% | 2,781,144 | 361.51M |
| 432 | TCMD | Tactile Systems Technology, Inc. | 594.36M | 1.46% | 141,235 | 343.52M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 594.22M | 3.71% | 549,979 | - |
| 434 | RIGL | Rigel Pharmaceuticals, Inc. | 593.55M | 3.79% | 355,977 | 299.77M |
| 435 | BWAY | BrainsWay Ltd. | 571.60M | 3.82% | 64,910 | 56.22M |
| 436 | ACHV | Achieve Life Sciences, Inc. | 566.68M | -4.00% | 2,771,019 | - |
| 437 | IMMX | Immix Biopharma, Inc. | 565.30M | -0.98% | 1,074,274 | - |
| 438 | PHR | Phreesia, Inc. | 559.40M | -0.98% | 1,012,098 | 495.59M |
| 439 | GYRE | Gyre Therapeutics, Inc. | 553.71M | 1.68% | 75,104 | 117.05M |
| 440 | TECX | Tectonic Therapeutic, Inc. | 553.62M | 5.13% | 158,824 | - |
| 441 | MDXG | MiMedx Group, Inc. | 549.61M | 1.37% | 1,122,209 | 389.42M |
| 442 | CTEV | Claritev Corporation | 546.04M | 7.70% | 111,275 | 978.76M |
| 443 | NPCE | NeuroPace, Inc. | 540.04M | 0.83% | 96,083 | 99.53M |
| 444 | FLGT | Fulgent Genetics, Inc. | 533.36M | -0.79% | 258,296 | 320.35M |
| 445 | AQST | Aquestive Therapeutics, Inc. | 528.15M | 5.51% | 1,890,748 | 50.27M |
| 446 | XOMA | XOMA Royalty Corporation | 524.22M | 0.10% | 142,877 | 48.56M |
| 447 | DNA | Ginkgo Bioworks Holdings, Inc. | 522.60M | 0.76% | 1,010,456 | 151.40M |
| 448 | CLYM | Climb Bio, Inc. | 521.15M | 0.97% | 1,111,988 | - |
| 449 | CTKB | Cytek Biosciences, Inc. | 519.15M | -0.74% | 2,389,717 | 204.17M |
| 450 | CERS | Cerus Corporation | 518.96M | 1.17% | 3,859,705 | 216.56M |
| 451 | EVH | Evolent Health, Inc. | 515.16M | 2.46% | 1,707,925 | 1.89B |
| 452 | TOI | The Oncology Institute, Inc. | 512.91M | 9.62% | 1,931,485 | 545.76M |
| 453 | PRME | Prime Medicine, Inc. | 509.34M | 4.06% | 2,502,532 | 4.03M |
| 454 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 455 | ALT | Altimmune, Inc. | 503.69M | -0.77% | 3,425,321 | 36.00K |
| 456 | ANGO | AngioDynamics, Inc. | 503.52M | -1.63% | 172,760 | 313.73M |
| 457 | PROK | ProKidney Corp. | 501.42M | -0.60% | 587,829 | 889.00K |
| 458 | CABA | Cabaletta Bio, Inc. | 490.79M | -0.99% | 3,127,179 | - |
| 459 | AGMB | AgomAb Therapeutics NV | 486.57M | -4.36% | 136,075 | - |
| 460 | VALN | Valneva SE | 483.84M | 0.57% | 19,406 | 180.25M |
| 461 | KYTX | Kyverna Therapeutics, Inc. | 476.37M | 2.74% | 562,516 | - |
| 462 | SRTA | Strata Critical Medical, Inc. | 475.03M | 0.18% | 1,202,809 | 228.58M |
| 463 | VREX | Varex Imaging Corporation | 464.88M | 4.84% | 300,365 | 857.50M |
| 464 | FDMT | 4D Molecular Therapeutics, Inc. | 461.86M | 1.32% | 675,219 | 88.24M |
| 465 | EIKN | Eikon Therapeutics, Inc. | 461.26M | 1.56% | 248,150 | - |
| 466 | NGNE | Neurogene Inc. | 458.26M | 3.53% | 127,099 | 925.00K |
| 467 | KIDS | OrthoPediatrics Corp. | 457.96M | -3.41% | 76,439 | 243.30M |
| 468 | ARVN | Arvinas, Inc. | 457.46M | 1.58% | 817,334 | 89.40M |
| 469 | ASMB | Assembly Biosciences, Inc. | 446.48M | 0.90% | 290,546 | 71.10M |
| 470 | CTNM | Contineum Therapeutics, Inc. | 443.40M | 5.04% | 127,409 | - |
| 471 | STRO | Sutro Biopharma, Inc. | 438.79M | 1.49% | 238,878 | 99.61M |
| 472 | MYGN | Myriad Genetics, Inc. | 437.30M | 4.51% | 1,711,848 | 829.00M |
| 473 | WEAV | Weave Communications, Inc. | 434.43M | -2.15% | 975,287 | 248.72M |
| 474 | EBS | Emergent BioSolutions Inc. | 432.89M | 1.82% | 678,008 | 676.80M |
| 475 | PRTA | Prothena Corporation plc | 432.44M | 4.42% | 634,185 | 57.94M |
| 476 | EOLS | Evolus, Inc. | 428.71M | -3.12% | 630,953 | 301.79M |
| 477 | CCCC | C4 Therapeutics, Inc. | 427.90M | - | 2,227,484 | 34.86M |
| 478 | FBRX | Forte Biosciences, Inc. | 425.18M | 3.45% | 172,223 | - |
| 479 | NRC | NRC Health | 423.46M | -11.70% | 261,843 | 138.64M |
| 480 | KMDA | Kamada Ltd. | 420.42M | 3.19% | 25,828 | 181.68M |
| 481 | PACB | Pacific Biosciences of California, Inc. | 419.31M | -1.46% | 5,069,275 | 160.03M |
| 482 | AUTL | Autolus Therapeutics plc | 415.18M | 5.41% | 923,484 | 92.62M |
| 483 | CLPT | ClearPoint Neuro, Inc. | 415.06M | 0.65% | 359,403 | 40.61M |
| 484 | CYH | Community Health Systems, Inc. | 413.13M | 2.69% | 2,627,387 | 12.29B |
| 485 | OCGN | Ocugen, Inc. | 413.00M | 2.52% | 4,858,313 | 4.47M |
| 486 | OVID | Ovid Therapeutics Inc. | 412.47M | -3.07% | 2,883,204 | 7.12M |
| 487 | CCRN | Cross Country Healthcare, Inc. | 409.00M | 0.08% | 357,310 | 1.00B |
| 488 | ANL | Adlai Nortye Ltd. | 408.00M | -3.63% | 109,965 | 5.00M |
| 489 | PRLD | Prelude Therapeutics Incorporated | 407.62M | 4.05% | 204,867 | 16.72M |
| 490 | MOBI | Mobia Medical, Inc. | 407.61M | -3.14% | 165,706 | 32.04M |
| 491 | DCTH | Delcath Systems, Inc. | 406.15M | 5.14% | 809,047 | 90.44M |
| 492 | INDP | Indaptus Therapeutics, Inc. | 404.28M | 45.71% | 4,238,770 | - |
| 493 | IPSC | Century Therapeutics, Inc. | 403.99M | 5.66% | 692,838 | 109.16M |
| 494 | RZLT | Rezolute, Inc. | 403.24M | 1.31% | 1,151,073 | - |
| 495 | VMD | Viemed Healthcare, Inc. | 399.47M | 2.86% | 182,787 | 286.57M |
| 496 | SGMT | Sagimet Biosciences Inc. | 397.06M | -1.08% | 763,642 | - |
| 497 | MNPR | Monopar Therapeutics Inc. | 395.86M | -0.55% | 79,071 | - |
| 498 | EPRX | Eupraxia Pharmaceuticals Inc. | 392.77M | 1.86% | 213,587 | - |
| 499 | VTVT | vTv Therapeutics Inc. | 392.02M | 4.27% | 30,977 | 36.84M |
| 500 | SI | Shoulder Innovations, Inc. | 389.05M | 4.86% | 128,800 | 53.89M |